Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Brandenburg CAMPUS GmbH
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 13 October 2025
First Online: 1 November 2025
Declarations
:
: Author Sonya Faber is employed by Angelini Pharma and is a partner in the company Bioville GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The other authors declare no conflicts of interest.
